NEWS & EVENTS

Press Releases

Boston Pharmaceuticals Acquires Three Novel Anti-Infective Programs from Novartis

10/3/2018

10/3/2018

Boston Pharmaceuticals Adds Five New Drug Programs to Its Pipeline in Licensing Deal

2/6/2018

Boston Pharmaceuticals to Present at 2018 BIO CEO & Investor Conference

1/4/2018

Pierre Fabre Enters Worldwide Licensing Agreement with Boston Pharmaceuticals for a Selective Potassium Channel Blocker for Atrial Fibrillation

1/3/2018

Boston Pharmaceuticals Appoints Dr. Peter Ho as Chief Medical Officer

8/28/2017

Daiichi Sankyo Enters Worldwide Licensing Agreement with Boston Pharmaceuticals for a Highly Selective RET Inhibitor for Solid Tumors

Upcoming Events

EUROPEAN LIFE SCIENCES CEO FORUM February 25-26, Zurich

EUROPEAN LIFE SCIENCES CEO FORUM
February 25-26, Zurich

BIO ASIA March 5-6, Tokyo

BIO ASIA
March 5-6, Tokyo

BIO EUROPE SPRING March 25-27, Vienna

BIO EUROPE SPRING
March 25-27, Vienna